Bristol-Myers Squibb Foundation donates grants in Asia as part of Delivering Hope programme for Hepatitis B and Hepatitis C.
M2 PHARMA-February 20, 2012-Bristol-Myers Squibb Foundation donates grants in Asia as part of Delivering Hope programme for Hepatitis B and Hepatitis C(C)2012 M2 COMMUNICATIONS
Bristol-Myers Squibb Foundation on Friday awarded three new grants to improve prevention, diagnosis and care of hepatitis B (HBV) and hepatitis C (HCV) in China and India at the Asian Pacific Association for the Study of the Liver (APASL) 2012 Conference in Taipei, Taiwan as part of its Delivering Hope programme.
This Awareness, Prevention and Care umbrella programme is committed to reducing hepatitis-related health disparities in Asia. China and India together have an estimated 123m people chronically infected with HBV and 59m people chronically infected with HCV, accounting for almost 50% of all HBV and HCV infections worldwide.
According to the company, the grant recipients include The Chinese Foundation for Hepatitis Prevention and Control (CFHPC), The Shanghai Charity Foundation (China) and The Liver Foundation, West Bengal (India).
The Bristol-Myers Squibb Foundation is an independent charitable organisation whose mission is to reduce health disparities and improve health outcomes around the world for patients disproportionately affected by serious disease and is part of Bristol-Myers Squibb.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 20, 2012|
|Previous Article:||James E Cary Cancer Center places order for RayStation.|
|Next Article:||Corcept Therapeutics Incorporated receives FDA approval of Korlym 300 mg tablets for patients with Cushinga[euro](tm)s Syndrome.|